You are here: Industry Insights > acquisition

News List

Genentech Acquires Jecure Therapeutics americanpharmaceuticalreview
November 29, 2018
Jecure Therapeutics announced a definitive agreement by which it will be acquired by Genentech, a member of the Roche Group. With this acquisition, Genentech will obtain full rights to Jecure’s entire preclinical portfolio of NLRP3 inhibitors......
Sun Pharmaceutical agrees to acquire Japan’s Pola Pharma pharmaceutical
November 29, 2018
India-based drugmaker Sun Pharmaceutical Industries has signed a definitive agreement to acquire Pola Pharma, a Japan-based pharma firm involved in the research, development, manufacture, and sale of branded and generic products......
Q BioMed Acquires Metastron from GE Healthcare americanpharmaceuticalreview
November 29, 2018
Q BioMed has entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron, from GE Healthcare....
Two Labs Acquires Pennside Partners Ltd. pharmafocusasia
November 28, 2018
Industry-leading pharmaceutical services company, Two Labs, today announced it has acquired Pennside Partners Ltd., an international provider of market insights....
Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion pharmafocusasia
November 28, 2018
Endocyte, Inc., a biopharmaceutical company developing targeted therapeutics for cancer treatment, today announced that it has entered into an agreement .....
Cherry acquired by communications group Avenir pharmaphorum
November 28, 2018
UK healthcare creative agency Cherry has been acquired by Avenir Global in a move that strengthens its European presence.
Cambrex Buys Avista for $252M contractpharma
November 27, 2018
Cambrex has entered into a definitive agreement to acquire Avista Pharma Solutions for roughly $252 million. Avista is a portfolio company of Ampersand Capital Partners.
Telix to Acquire ANMI for €5.15M contractpharma
November 27, 2018
Telix Pharmaceuticals Limited has announced the acquisition of Advanced Nuclear Medicine Ingredients (ANMI) SA for €5.15m in cash and shares.
Exscientia builds AI capability with Kinetic acquisition pharmaphorum
November 27, 2018
There is huge focus on the potential of artificial intelligence (AI) in drug discovery – and Exscientia is another UK company building its capability in this area.
Sun gets dermatology portfolio, two plants in Japan with Pola Pharma deal expressbpd
November 27, 2018
Acquisition to help in building global dermatology business

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page